DEBBANE RAYMOND 内部人交易：近期 SEC Form 4 交易
过去 18 个月，DEBBANE RAYMOND（CIK 1053890）在 2 家公司共报告 14 笔 SEC Form 4 内部人交易（最近一笔 2026-06-04）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 89,312 | $0 |
| 2026-02-27 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 2,000 | $2,980 |
| 2026-02-25 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 100,000 | $147,000 |
| 2026-02-23 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 50,000 | $72,000 |
| 2026-02-23 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 100,000 | $148,000 |
| 2026-02-18 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 57,952 | $75,917 |
| 2026-02-18 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 76,857 | $100,683 |
| 2026-02-18 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 133,688 | $176,468 |
| 2026-02-06 | Scholar Rock Holding Corp (SRRK) | 10% 以上股东 | 买入 | 1.6M | $11.6M |
| 2026-02-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 18.6M | $24.1M |
| 2026-02-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 3.8M | $5.0M |
| 2026-02-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 1.5M | $2.0M |
| 2026-02-04 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 367,145 | $23.9M |
| 2025-05-13 | LEXICON PHARMACEUTICALS, INC. (LXRX) | 董事 | 买入 | 36,810 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-04